Benedetto Vitiello
#132,388
Most Influential Person Now
Researcher
Benedetto Vitiello's AcademicInfluence.com Rankings
Benedetto Vitiellocomputer-science Degrees
Computer Science
#5884
World Rank
#6208
Historical Rank
Machine Learning
#1730
World Rank
#1753
Historical Rank
Artificial Intelligence
#1973
World Rank
#2007
Historical Rank
Database
#3009
World Rank
#3137
Historical Rank
Download Badge
Computer Science
Benedetto Vitiello's Degrees
- PhD Computer Science University of Milan
- Masters Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Benedetto Vitiello Influential?
(Suggest an Edit or Addition)Benedetto Vitiello's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. (1999) (3124)
- Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. (2001) (1190)
- Risperidone in children with autism and serious behavioral problems. (2002) (1186)
- The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. (2009) (1130)
- Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. (2004) (1118)
- Challenges and burden of the Coronavirus 2019 (COVID-19) pandemic for child and adolescent mental health: a narrative review to highlight clinical and research needs in the acute phase and the long return to normality (2020) (1052)
- Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. (2001) (1024)
- ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. (2001) (935)
- Rehabilitation of persons with traumatic brain injury. (1999) (831)
- 3-year follow-up of the NIMH MTA study. (2007) (625)
- Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. (1999) (606)
- Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. (2008) (570)
- Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and Applications for Primary Care Providers (2001) (562)
- National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. (2004) (561)
- Parent-Rated Anxiety Symptoms in Children with Pervasive Developmental Disorders: Frequency and Association with Core Autism Symptoms and Cognitive Functioning (2008) (558)
- The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. (2007) (530)
- Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. (2005) (486)
- Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. (2001) (453)
- The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. (2002) (449)
- Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. (2002) (448)
- Symptom profiles in children with ADHD: effects of comorbidity and gender. (2001) (426)
- Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. (2008) (419)
- Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. (2006) (414)
- Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. (2005) (406)
- Subtypes of aggression and their relevance to child psychiatry. (1997) (398)
- Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). (2006) (393)
- Observed Classroom Behavior of Children with ADHD: Relationship to Gender and Comorbidity (2002) (374)
- National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. (2004) (351)
- Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. (1993) (328)
- Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. (2007) (320)
- Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. (2009) (294)
- Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. (1996) (287)
- Family Processes and Treatment Outcome in the MTA: Negative/Ineffective Parenting Practices in Relation to Multimodal Treatment (2000) (287)
- Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. (2001) (284)
- Which treatment for whom for ADHD? Moderators of treatment response in the MTA. (2003) (283)
- Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptability. (2009) (281)
- Suicide Attempts and Nonsuicidal Self-Injury in the Treatment of Resistant Depression in Adolescents: Findings from the TORDIA Study (2012) (280)
- Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. (2001) (277)
- Suicide attempts and nonsuicidal self-injury in the treatment of resistant depression in adolescents: findings from the TORDIA study. (2011) (277)
- Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. (2000) (274)
- Peer-Assessed Outcomes in the Multimodal Treatment Study of Children With Attention Deficit Hyperactivity Disorder (2005) (265)
- Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice. (1999) (252)
- Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). (2006) (249)
- Anxiety as a Predictor and Outcome Variable in the Multimodal Treatment Study of Children with ADHD (MTA) (2000) (247)
- The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) (242)
- Parenting and Family Stress Treatment Outcomes in Attention Deficit Hyperactivity Disorder (ADHD): An Empirical Analysis in the MTA Study (2000) (238)
- Safety and tolerability of methylphenidate in preschool children with ADHD. (2006) (232)
- Gastrointestinal Symptoms in a Sample of Children with Pervasive Developmental Disorders (2009) (227)
- Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. (2013) (226)
- Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. (2007) (224)
- The role of anxiety symptoms in school performance in a community sample of children and adolescents (2007) (216)
- The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial. (2009) (210)
- Stimulant-related reductions of growth rates in the PATS. (2006) (206)
- Use of mental health and substance abuse treatment services among adults with HIV in the United States. (2001) (206)
- Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months. (2005) (205)
- Stimulant medication use in children: a 12-year perspective. (2012) (203)
- Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. (2009) (200)
- Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. (2003) (194)
- Recent trends in stimulant medication use among U.S. children. (2006) (193)
- Young adult outcomes in the follow‐up of the multimodal treatment study of attention‐deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression (2017) (191)
- Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns (2009) (189)
- Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. (2009) (188)
- Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model (1992) (187)
- The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up. (2013) (185)
- Treatment for Adolescents with Depression Study (TADS): safety results. (2006) (178)
- Exploring the Manifestations of Anxiety in Children with Autism Spectrum Disorders (2013) (172)
- Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. (2006) (171)
- Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. (2001) (169)
- The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks. (2006) (168)
- Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods. (2003) (166)
- Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. (2000) (164)
- Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. (2005) (160)
- Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. (2003) (154)
- Subtyping aggression in children and adolescents. (1990) (153)
- Acute and long-term safety and tolerability of risperidone in children with autism. (2005) (150)
- Validity of the autism diagnostic interview-revised. (2006) (145)
- Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. (2007) (144)
- Effects of Short- and Long-Term Risperidone Treatment on Prolactin Levels in Children with Autism (2007) (142)
- Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (141)
- Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes. (2009) (138)
- Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity (2017) (138)
- Assessing medication effects in the MTA study using neuropsychological outcomes. (2006) (137)
- Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS). (2006) (136)
- Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies. (2007) (136)
- Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study. (2010) (135)
- Positive Effects of Methylphenidate on Social Communication and Self-Regulation in Children with Pervasive Developmental Disorders and Hyperactivity (2009) (133)
- A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. (2012) (132)
- Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes. (2010) (130)
- The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. (2009) (130)
- The Transition to Middle School is Associated with Changes in the Developmental Trajectory of ADHD Symptomatology in Young Adolescents with ADHD (2008) (127)
- Positive Effects of Methylphenidate on Inattention and Hyperactivity in Pervasive Developmental Disorders: An Analysis of Secondary Measures (2007) (127)
- Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. (2007) (124)
- Pharmacogenetics of methylphenidate response in preschoolers with ADHD. (2006) (123)
- Treatment for Adolescents with Depression Study (TADS) (2008) (122)
- Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data. (2004) (122)
- Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders. (2005) (120)
- Unmet need for services and interventions among adolescents with mental disorders. (2007) (116)
- Socioeconomic status as a moderator of ADHD treatment outcomes. (2002) (116)
- Suicidal events in the Treatment for Adolescents With Depression Study (TADS). (2009) (115)
- Assessment in Multisite Randomized Clinical Trials of Patients with Autistic Disorder: The Autism RUPP Network (2000) (115)
- Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS). (2006) (115)
- Medication development and testing in children and adolescents. Current problems, future directions. (1997) (113)
- Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (111)
- A prospective open trial of guanfacine in children with pervasive developmental disorders. (2006) (110)
- Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. (2011) (110)
- Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. (2006) (110)
- Use of psychotropic medications among HIV-infected patients in the United States. (2003) (109)
- Behavioural and Temperamental Characteristics of Children and Adolescents Suffering from Primary Headache (2006) (105)
- Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function. (2008) (105)
- Obsessive–compulsive traits in children and adolescents with Asperger syndrome (2009) (104)
- Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study. (2010) (103)
- Reduction of (3H)-imipramine binding sites on platelets of conduct-disordered children. (1987) (103)
- Evidence, Interpretation, and Qualification From Multiple Reports of Long-Term Outcomes in the Multimodal Treatment Study of Children With ADHD (MTA) (2008) (102)
- Cognitive and Behavioral Effects of Cholinergic, Dopaminergic, and Serotonergic Blockade in Humans (1997) (97)
- Familial Aggregation of ADHD Characteristics (2000) (95)
- Clinical messages from the Treatment for Adolescents With Depression Study (TADS). (2009) (95)
- Refining the diagnoses of inattention and overactivity syndromes: A reanalysis of the Multimodal Treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD-10 criteria for hyperkinetic disorder (2005) (93)
- Evidence, Interpretation, and Qualification From Multiple Reports of Long-Term Outcomes in the Multimodal Treatment Study of Children With ADHD (MTA) (2008) (92)
- Treatment of early-onset schizophrenia spectrum disorders (TEOSS): demographic and clinical characteristics. (2007) (91)
- Antidepressant medications in children. (2004) (90)
- Psychopharmacology for young children: clinical needs and research opportunities. (2001) (88)
- Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. (2004) (88)
- Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. (2012) (88)
- Risperidone and adaptive behavior in children with autism. (2006) (88)
- Psychological Impact of the COVID-19 Pandemic on Adults and Their Children in Italy (2020) (85)
- Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (85)
- Cost-effectiveness of treatments for adolescent depression: results from TADS. (2008) (83)
- Medication use in US youth with mental disorders. (2013) (83)
- Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (83)
- Development of a parent training program for children with pervasive developmental disorders (2007) (81)
- Impact of physical and sexual abuse on treatment response in the Treatment of Resistant Depression in Adolescent Study (TORDIA). (2011) (81)
- Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study. (2002) (80)
- National estimates of antidepressant medication use among U.S. children, 1997-2002. (2006) (80)
- Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. (2012) (79)
- Medication Management of Stimulants in Pediatric Practice Settings: A National Perspective (2000) (78)
- Review of safety assessment methods used in pediatric psychopharmacology. (2003) (78)
- Obsessive-Compulsive Disorder in Mentally Retarded Patients (1989) (77)
- Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment. (1998) (76)
- Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder. (2001) (76)
- Substance use through adolescence into early adulthood after childhood‐diagnosed ADHD: findings from the MTA longitudinal study (2018) (75)
- The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors (2016) (74)
- Parent-Reported Homework Problems in the MTA Study: Evidence for Sustained Improvement with Behavioral Treatment (2010) (74)
- Developmental Disabilities Modification of the Children’s Global Assessment Scale (2007) (70)
- Reliability of subtle (soft) neurological signs in children. (1989) (69)
- Childhood Mental Health Disorders: Evidence Base and Contextual Factors for Psychosocial, Psychopharmacological, and Combined Interventions (2007) (69)
- Effectiveness of Methylphenidate in the 10-Month Continuation Phase of the Preschoolers with ADHD Treatment Study (PATS) (2007) (67)
- Treatment of early-onset schizophrenia spectrum disorders (TEOSS): rationale, design, and methods. (2007) (67)
- Pediatric Psychopharmacology and the Interaction between Drugs and the Developing Brain (1998) (66)
- Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial. (2009) (66)
- Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study. (2009) (65)
- Research on eating disorders: current status and future prospects (2000) (64)
- Research in child and adolescent psychopharmacology: recent accomplishments and new challenges (2007) (64)
- How can we improve the assessment of safety in child and adolescent psychopharmacology? (2003) (64)
- Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. (2015) (63)
- Child and adolescent mental health service provision and research during the Covid-19 pandemic: challenges, opportunities, and a call for submissions (2020) (61)
- Cognitive effects of risperidone in children with autism and irritable behavior. (2008) (60)
- An exploration of concomitant psychiatric disorders in children with autism spectrum disorder. (2019) (59)
- Acute time to response in the Treatment for Adolescents with Depression Study (TADS). (2006) (59)
- Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. (2003) (59)
- Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. (2010) (58)
- Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist. (2014) (58)
- Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder. (2016) (58)
- Autonomic dysfunction in patients with dementia of the Alzheimer type (1993) (58)
- Substance use and the treatment of resistant depression in adolescents. (2009) (57)
- Alzheimer's disease and feeling-of-knowing for knowledge and episodic memory. (1992) (56)
- Dietary status and impact of risperidone on nutritional balance in children with autism: A pilot study (2006) (56)
- Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives (2015) (56)
- Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable? (2006) (55)
- Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies (2013) (54)
- Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (53)
- National trends in concomitant psychotropic medication with stimulants in pediatric visits: Practice versus knowledge (2004) (52)
- Nine Months of Multicomponent Behavioral Treatment for ADHD and Effectiveness of MTA Fading Procedures (2004) (50)
- Pharmacokinetics of lithium carbonate in children. (1988) (50)
- Hypericum perforatum Extracts as Potential Antidepressants (1998) (50)
- Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems. (2014) (49)
- Overweight and obese status in children with autism spectrum disorder and disruptive behavior (2018) (49)
- Economic Evaluation of Strategies to Reduce Sudden Cardiac Death in Young Athletes (2012) (48)
- Developmental perspectives in pediatric psychopharmacology. (1995) (48)
- Antidepressant Exposure as a Predictor of Clinical Outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) Study (2011) (48)
- Brief Report: Social Disability in Autism Spectrum Disorder: Results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network Trials (2013) (48)
- Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. (2012) (46)
- Developing strategies for psychopharmacological studies in preschool children. (2003) (46)
- Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism. (2001) (45)
- The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration (2004) (45)
- Modeled Economic Evaluation of Alternative Strategies to Reduce Sudden Cardiac Death Among Children Treated for Attention Deficit/Hyperactivity Disorder (2010) (45)
- Oppositional defiant and conduct disorders. (2008) (43)
- Ethical considerations in psychopharmacological research involving children and adolescents (2003) (43)
- Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings. (2011) (42)
- AACAP 2001 research forum: challenges and recommendations regarding recruitment and retention of participants in research investigations. (2004) (42)
- Do sub-syndromal manic symptoms influence outcome in treatment resistant depression in adolescents? A latent class analysis from the TORDIA study. (2012) (40)
- Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders (2013) (40)
- Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000. (2003) (40)
- An international perspective on pediatric psychopharmacology (2008) (40)
- Antidepressant prescribing practices for the treatment of children and adolescents. (2008) (40)
- Trial Design Challenges When Combining Medication and Parent Training in Children with Pervasive Developmental Disorders (2009) (40)
- Diagnosis of panic disorder in prepubertal children. (1990) (37)
- Neurocognition in early-onset schizophrenia and schizoaffective disorders. (2010) (36)
- Maternal anxiety, depression and sleep disorders before and during pregnancy, and preschool ADHD symptoms in the NINFEA birth cohort study (2018) (35)
- Assessing patient beliefs in a clinical trial of Hypericum perforatum in major depression (2004) (35)
- Assessment of safety and long-term outcomes of initial treatment with placebo in TADS. (2009) (35)
- Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study. (2009) (34)
- P.r.n. medications in child psychiatric patients: a pilot placebo-controlled study. (1991) (34)
- Research knowledge among parents of children participating in a randomized clinical trial. (2005) (33)
- Reliability of DSM-III diagnoses of hospitalized children. (1990) (32)
- Platelet imipramine binding and serotonin uptake in obsessive‐compulsive patients (1991) (32)
- Prevalence of psychiatric symptoms in children and adolescents one year after the 2009 L’Aquila earthquake (2014) (32)
- Dysmorphophobia misdiagnosed as obsessive-compulsive disorder. (1990) (32)
- Pubertal delay in male nonhuman primates (Macaca mulatta) treated with methylphenidate (2011) (32)
- Maladaptive Aggression: With a Focus on Impulsive Aggression in Children and Adolescents (2019) (31)
- Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government. (2006) (31)
- A manual-based intervention to address clinical crises and retain patients in the Treatment of Adolescents With Depression Study (TADS). (2007) (31)
- Mental retardation and psychiatric illness. (1992) (31)
- Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up. (2015) (31)
- Depression and Suicidality Outcomes in the Treatment of Early Age Mania Study. (2015) (30)
- AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology. (2004) (30)
- Combined Cognitive-Behavioural Therapy and Pharmacotherapy for Adolescent Depression (2009) (30)
- Safeguarding children's rights in psychopharmacological research: ethical and legal issues. (2010) (29)
- Impact of war and forced displacement on children’s mental health—multilevel, needs-oriented, and trauma-informed approaches (2022) (29)
- Design and methodology issues for clinical treatment trials in children and adolescents. Child and adolescent psychopharmacology: expanding the research base. (1994) (29)
- Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study. (2012) (29)
- Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study (2007) (29)
- Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy. (2008) (28)
- Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder. (2001) (28)
- Response to Commentary on the Multimodal Treatment Study of ADHD (MTA): Mining the Meaning of the MTA (2002) (27)
- Sources of site differences in the efficacy of a multisite clinical trial: the Treatment of SSRI-Resistant Depression in Adolescents. (2009) (27)
- Integrating science and ethics in child and adolescent psychiatry research (1999) (27)
- The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present (2021) (27)
- Pharmacological treatment of children and adolescents with depression (2016) (26)
- Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity. (2010) (26)
- Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. (2011) (26)
- Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (26)
- Soft Neurological Signs and Impulsivity in Children (1990) (26)
- Peer-reviewed, high quality, worldwide information on all topics relevant to child and adolescent mental health (2007) (26)
- Elevated platelet MAO is related to impulsivity in disruptive behavior disorders. (1989) (26)
- Datapoints: trends in combined pharmacotherapy with stimulants for children. (2002) (25)
- Clinical Correlates of Parenting Stress in Children with Autism Spectrum Disorder and Serious Behavioral Problems (2019) (24)
- Children's hospitalizations with a mood disorder diagnosis in general hospitals in the united states 2000-2006 (2011) (24)
- Development of a Physiologically Based Model to Describe the Pharmacokinetics of Methylphenidate in Juvenile and Adult Humans and Nonhuman Primates (2014) (24)
- Does multimodal treatment of ADHD decrease other diagnoses? (2005) (24)
- Introduction: Current Knowledge and Unmet Needs in Pediatric Psychopharmacology (1999) (24)
- P.R.N. medications in child state hospital inpatients. (1987) (23)
- Platelet 3H-imipramine binding, serotonin uptake, and plasma α 1 acid glycoprotein in disruptive behavior disorders (1991) (23)
- Factors associated with recruitment and screening in the Treatment for Adolescents With Depression Study (TADS). (2007) (23)
- HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people (2007) (22)
- Lower IQ is Associated with Decreased Clinical Response to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder (2011) (22)
- ESCAP CovCAP survey of heads of academic departments to assess the perceived initial (April/May 2020) impact of the COVID-19 pandemic on child and adolescent psychiatry services (2021) (21)
- Treatment of adolescent depression: what we have come to know (2009) (21)
- Service Use and Costs of Care for Depressed Adolescents: Who Uses and Who Pays? (2009) (20)
- Improving Access to Effective Care for People Who Have Mental Health and Substance Use Disorders: A Vital Direction for Health and Health Care (2016) (20)
- Skating to where the puck is going to be: a plan for clinical trials and translation research in mood disorders (2002) (20)
- Hyperforin Plasma Level as a Marker of Treatment Adherence in the National Institutes of Health Hypericum Depression Trial (2005) (20)
- The effects of thyrotropin-releasing hormone and scopolamine in Alzheimer's disease and normal volunteers (1992) (20)
- Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al. (2005) (20)
- Stimulant treatment of ADHD and risk of sudden death in children. (2009) (19)
- Where have the children with epilepsy gone? An observational study of seizure-related accesses to emergency department at the time of COVID-19 (2020) (19)
- Effectively Obtaining Informed Consent for Child and Adolescent Participation in Mental Health Research (2008) (19)
- Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution. (2002) (18)
- Pharmacoepidemiology and pediatric psychopharmacology research. (2005) (18)
- New Formulations of Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy, and Tolerability (2017) (18)
- Prevention and treatment of child and adolescent depression: challenges and opportunities (2011) (18)
- Psychiatric symptoms and comorbidities in autism spectrum disorder (2016) (18)
- Pharmacotherapy of bipolar disorder in children and adolescents (2006) (17)
- Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder. (2017) (17)
- Treatment of Early-Age Mania: Outcomes for Partial and Nonresponders to Initial Treatment. (2015) (17)
- Lack of seasonal variation in the births of patients with dementia of the Alzheimer type (1991) (16)
- Cigarette Smoking Progression Among Young Adults Diagnosed With ADHD in Childhood: A 16-year Longitudinal Study of Children With and Without ADHD. (2019) (16)
- Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental Disorders (2013) (16)
- Open-label amantadine in children with attention-deficit/hyperactivity disorder. (2007) (16)
- Pediatric pharmacoepidemiology: clinical applications and research priorities in children's mental health. (1997) (16)
- Clinical and personality characteristics of adolescents with anorexia nervosa with or without non-suicidal self-injurious behavior. (2019) (16)
- Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis. (1990) (15)
- Prevalence of severe ADHD: an epidemiological study in the Italian regions of Tuscany and Latium (2014) (15)
- Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS). (2007) (15)
- Part I: Executive Summary (2008) (15)
- An update on publicly funded multisite trials in pediatric psychopharmacology. (2006) (15)
- Approaches to multisite clinical trials: the National Institute of Mental Health perspective. (2003) (14)
- Reduced cerebrospinal fluid dynorphin A1–8 in Alzheimer's disease (1991) (14)
- Recent developments and strategies in pediatric pharmacology research in the USA (2008) (13)
- A depressed adolescent at high risk of suicidal behavior. (2008) (13)
- Long-Term Outcome of Adolescent Depression Initially Resistant to SSRI Treatment (2011) (13)
- Out of the black box: treatment of resistant depression in adolescents and the antidepressant controversy. (2012) (13)
- Panic disorder in prepubertal children. (1987) (13)
- Role of serotonin in aggression of children and adolescents: Biochemical and pharmacological studies. (1996) (12)
- Editorial Preface (2000) (12)
- Improving the methods for evaluating the safety of psychotropic medications in children and adolescents (2001) (12)
- Pharmacotherapy for Children and Adolescents with Anxiety Disorders (2010) (12)
- Does population density moderate suicide risk? An Italian population study over the last 30 years (2020) (12)
- Gestational and postnatal tobacco smoke exposure as predictor of ADHD, comorbid ODD/CD, and treatment response in the MTA (2005) (12)
- Psychotic Symptoms in Attention-Deficit/Hyperactivity Disorder: An Analysis of the MTA Database. (2017) (11)
- Reciprocal changes in psychosis and mood after physostigmine in a patient with Alzheimer's disease. (1991) (11)
- Selecting an antidepressant for the treatment of pediatric depression. (2006) (11)
- Autism spectrum disorders and mental retardation. (2008) (11)
- Developmental Disabilities Modification of Children’s Global Assessment Scale (DD-CGAS) psychometrics (2007) (11)
- New pharmacotherapies for genetic neuromuscular disorders: opportunities and challenges (2019) (11)
- Twenty years of progress in paediatric psychopharmacology: accomplishments and unmet needs (2018) (10)
- Toward clinically relevant clinical trials. (1997) (10)
- Anticonvulsants for Psychiatric Disorders in Children and Adolescents: A Systematic Review of Their Efficacy (2018) (10)
- Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (10)
- Blindness of clinical evaluators, parents, and children in a placebo-controlled trial of fluvoxamine. (2006) (10)
- Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of d-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment (2006) (10)
- Treatment algorithms in child psychopharmacology research. (1997) (9)
- A multisite psychotherapy and medication trial for depressed adolescents: Background and benefits (2005) (9)
- Comparative efficacy of cognitive behavioral therapy, fluoxetine, and their combination in depressed adolescents: Initial lessons from the treatment for adolescents with depression study (2005) (9)
- A psychological support group for parents in the care of families with gender diverse children and adolescents (2020) (9)
- VALPROIC ACID AND RISPERIDONE: Commentary (2001) (9)
- Sensitivity of the modified Children’s Yale–Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials (2016) (9)
- Reporting clinical trials of psychosocial interventions in child and adolescent psychiatry and mental health (2011) (9)
- Mutations in sphingolipid metabolism genes are associated with ADHD (2020) (8)
- Psychopharmacology in HIV-positive patients: research perspectives. (1996) (8)
- The Rapidly Expanding Field of Autism Research (2007) (8)
- What Do We Know about the Long-Term Course of Early Onset Bipolar Disorder? A Review of the Current Evidence (2021) (8)
- Psychopharmacology in Children and Adolescents: Current Problems, Future Prospects: Summary Notes on the 1995 NIMH-FDA Conference (1995) (8)
- Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper (2021) (8)
- Use of atypical antipsychotics in children: balancing safety and effectiveness. (2010) (7)
- School-Based Interventions for Students With Attention Deficit Hyperactivity Disorder: Research Implications and Prospects (2007) (7)
- Affectionless control: A parenting style associated with obesity and binge eating disorder in adulthood. (2020) (7)
- Current knowledge, challenges and innovations in developmental pharmacology: a combined c4c expert group and ESDPPP White paper. (2021) (7)
- Mental Health and Substance Abuse Issues Among People with HIV: Lessons from HCSUS (2007) (7)
- Mental Health and Substance Abuse Issues Among People with HIV (2007) (6)
- Principles in using psychotropic medications in children and adolescents (2012) (6)
- Combined Cognitive-Behavioral Therapy and Pharmacotherapy for Adolescent Depression: Does it Improve Outcomes Compared with Monotherapy? (2009) (6)
- The genetic toxicity of methylphenidate: a review of the current literature (2012) (6)
- Improving decision making in the treatment of ADHD. (2008) (6)
- Practical Clinical Trials in Psychopharmacology: A Systematic Review (2015) (6)
- Assessment of the Integrity of Study Blindness in a Pediatric Clinical Trial of Risperidone (2005) (6)
- Handbook of Child and Adolescent Psychopharmacology (2006) (5)
- Youth depression: are two treatments better than one? (2019) (5)
- Long-term outcomes in the Multimodal Treatment study of Children with ADHD (the MTA) (2018) (5)
- Emotional Dysregulation and Adaptive Functioning in Preschoolers With Autism Spectrum Disorder or Other Neurodevelopmental Disorders (2022) (5)
- Enhanced Expression of Human Endogenous Retroviruses, TRIM28 and SETDB1 in Autism Spectrum Disorder (2022) (5)
- Recent NIMH clinical trials and implications for practice. (2008) (5)
- Beware of Over-Interpreting Negative Trials (2008) (5)
- Tyrosyl Kinase Activity Is Inversely Related to Prostatic Acid Phosphatase Activity in Two Human Prostate Carcinoma Cell Lines (2003) (5)
- ADHD psychopharmacology across the lifespan (2009) (5)
- No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder. (2015) (5)
- Future directions and implications. (2008) (5)
- Semantic coherence markers: The contribution of perplexity metrics (2022) (4)
- Selective serotonin reuptake inhibitors (SSRIs) in children and adolescents. (2006) (4)
- Trends in admissions to a child and adolescent neuropsychiatric inpatient unit in the 2007–2017 decade: how contemporary neuropsychiatry is changing in Northwestern Italy (2021) (4)
- Plasma and salivary nortriptyline concentrations in a patient with black tongue. (1990) (4)
- Psychopathology and Adaptive Functioning in Children, Adolescents, and Young Adults with Noonan Syndrome (2021) (4)
- Understanding the Risk of Using Medications for ADHD with Respect to Physical Growth and Cardiovascular Function (2008) (4)
- Toward Precision Medicine in ADHD (2022) (4)
- Optimizing the Treatment of Adolescent Depression (2011) (3)
- Sexual Differences in Internet Gaming Disorder (IGD): From Psychological Features to Neuroanatomical Networks (2022) (3)
- Acute Hemichorea Can Be the Only Clinical Manifestation of Post-Varicella Vasculopathy: Two Pediatric Clinical Cases (2018) (3)
- Government Initiatives in Autism Clinical Trials (2004) (3)
- Association between EEG Paroxysmal Abnormalities and Levels of Plasma Amino Acids and Urinary Organic Acids in Children with Autism Spectrum Disorder (2022) (3)
- Introduction: Issues and viewpoints in pediatric psychopharmacology (2008) (3)
- Assessing Cognitive Function in Neuromuscular Diseases: A Pilot Study in a Sample of Children and Adolescents (2021) (3)
- The development of targeted neurobiological therapies in child and adolescent psychiatry. (2013) (3)
- Reliability and validity of the DICA. (1988) (3)
- Correction to: ESCAP CovCAP survey of heads of academic departments to assess the perceived initial (April/May 2020) impact of the COVID-19 pandemic on child and adolescent psychiatry services (2021) (3)
- Current research highlights in child and adolescent psychopharmacology (2000) (3)
- The Links between Infections and Psychiatric Diseases (1997) (3)
- Development of a Symptom-Focused Model to Guide the Prescribing of Antipsychotics in Children and Adolescents: Results of the First Phase of the Safer and Targeted Use of Antipsychotics (SUAY) Clinical Trial. (2021) (3)
- Reduced Cerebrospinal Fluid Dynorphin in Alzheimer's Disease (1991) (3)
- Depressive disorders and suicidality. (2008) (3)
- Obituary for Lutz Goldbeck (2018) (3)
- Obsessive–compulsive symptoms in young women affected with anorexia nervosa, and their relationship with personality, psychopathology, and attachment style (2021) (2)
- HIGH‐DOSE OLANZAPINE IN AN ADOLESCENT (1999) (2)
- Pediatric Psychopharmacology (2016) (2)
- Acute Tolerability of Methylphenidate in Treatment-Naïve Children with ADHD: An Analysis of Naturalistically Collected Data from Clinical Practice (2022) (2)
- COGNITIVE EFFECTS OF LONG‐TERM DEPRENYL AND HYDERGINE IN ALZHEIMER'S DISEASE PATIENTS (1992) (2)
- Prevention and treatment of the psychological consequences of trauma in children and adolescents (2004) (2)
- CRISIS AFAR: an international collaborative study of the impact of the COVID-19 pandemic on mental health and service access in youth with autism and neurodevelopmental conditions (2023) (2)
- The association of attachment, mentalization and reflective functioning with mental health in gender diverse children and adolescents: A systematic review (2022) (2)
- Safer use of antipsychotics in youth (SUAY) pragmatic trial protocol. (2020) (2)
- Gender Differences in Treatment-Seeking Youth with Autism Spectrum Disorder (2021) (2)
- Epilepsy in a cohort of children with Noonan syndrome and related disorders (2022) (2)
- Developmental Disability--Children's Global Assessment Scale (2015) (2)
- Editorial: Targeting the Core Symptoms of Autism Spectrum Disorder With Mechanism-based. (2020) (2)
- HIGH-DOSE OLANZAPINE IN AN ADOLESCENT. COMMENTARIES (1999) (2)
- Saliva lithium monitoring. (1987) (2)
- Emotional imagination of negative situations: Functional neuroimaging in anorexia and bulimia (2021) (2)
- How Effective are the Current Treatments for Children Diagnosed with Manic/Mixed Bipolar Disorder? (2013) (2)
- Pharmacologic treatment of children and adolescents with impulsive aggression and related behaviors (2006) (1)
- Combined fluoxetine with cognitive-behavioral therapy vs. monotherapy in the treatment of adolescents with major depressive disorder. (2007) (1)
- Supersensitivity psychosis: A controlled prospective double-blind withdrawal study (1989) (1)
- Fenfluramine stimulates plasma prolactin and cortisol release in boys with disruptive behavior disorders (1989) (1)
- Development and application of a diagnostic and severity scale to grade post-operative pediatric cerebellar mutism syndrome (2021) (1)
- ADHD and the thyroid controversy. (1994) (1)
- Clinical and Instrumental Follow-Up of Childhood Absence Epilepsy (CAE): Exploration of Prognostic Factors (2022) (1)
- Schizophrenia spectrum disorders. (2008) (1)
- Practicing evidence-based pediatric psychopharmacology: essential concepts (2006) (1)
- Review for "Social withdrawal and gender differences: Clinical phenotypes and biological bases" (2021) (1)
- The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications (2023) (1)
- Dr. Vitiello et al. reply. (2013) (1)
- Closing the gap: unmet needs of individuals with impulsive aggressive behavior observed in children and adolescents (2020) (1)
- The transition from adolescence to adulthood in patients with schizophrenia: Challenges, opportunities and recommendations (2022) (1)
- Dr. Aman et al. reply (2010) (1)
- P.2.109 A double-blind placebo-controlled trial of risperidone in autistic disorder (2003) (1)
- Child and Adolescent Psychiatry and Mental Health – development of a new open-access journal (2008) (1)
- Functional Cholinergic Receptor Sensitivity: The Role of Drug Probes (1991) (1)
- Opportunities Psychopharmacology for Young Children: Clinical Needs and Research (2009) (1)
- Modelling the memory impairment of Alzheimer's disease: the use of pharmacological probes in humans (1992) (1)
- Child psychiatry services in Asia: evolving state of affairs? (2015) (1)
- Tourette's and tic disorders. (2008) (1)
- The Importance of the Discourse on the Method (2010) (1)
- Perspectives from the National Institute of Mental Health: Preventing or living with aids (1996) (1)
- Onset of treatment-resistant schizophrenia in an adolescent with undiagnosed autism (2021) (1)
- Working with Children with Autism Undergoing Health-Care Assessments in a Day Hospital Setting: A Perspective from the Health-Care Professionals (2023) (1)
- Excerpt From The Newsletter Of The International Association For Child And Adolescent Psychiatry And Allied Professions (IACAPAP) No IV, Summer 1996: Trends In Pediatric Psychopharmacology: Current Status (1996) (1)
- (Almost) before your eyes: Preference for face-like configurations in the prenatal life (2018) (1)
- Severity of Symptoms Scale (SSS) 1989 (2007) (0)
- Italian version of the Occupational Depression Inventory: Validity, reliability, and associations with health, economic, and work-life characteristics (2022) (0)
- Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental Disorders (2012) (0)
- Semantic Coherence Markers for the Early Diagnosis of the Alzheimer Disease (2023) (0)
- Obituary (1977) (0)
- Obituary (2018) (0)
- Psychopathological profile in children with Prader-Willi syndrome as compared with autism spectrum disorder. (2021) (0)
- Pharmacotherapy of anxiety disorders in children and adolescents (2006) (0)
- Scopolamine effects on the pressor response to thyrotropin-releasing hormone in humans. (1994) (0)
- Comprar Psychiatric Symptoms And Comorbidities In Autism Spectrum Disorder | Luigi Mazzone | 9783319296937 | Springer (2016) (0)
- Supersensitivity to subcutaneous lidocaine. (1990) (0)
- Ethical Issues in Pediatric Psychopharmacology Research (2002) (0)
- Sleep disturbances and emotional dysregulation in young children with autism spectrum, intellectual disability, or global developmental delay. (2023) (0)
- Pharmacotherapy of psychotic disorders in children and adolescents (2006) (0)
- Erratum: Correction (The Journal of clinical psychiatry (2011) 72 3 (388-396) PII: 19lcx13039) (2019) (0)
- Improving Recognition of Treatable Rare Neuromuscular Disorders in Primary Care: A Pilot Feasibility Study (2022) (0)
- Exploring the Manifestations of Anxiety in Children with Autism Spectrum Disorders (2013) (0)
- Treatment of Early-Onset Schizophrenia Spectrum disorders (TEOSS) (2018) (0)
- Emotional responsiveness task in emotional distress: correlated of functional neuroimaging in anorexia and bulimia (2020) (0)
- Performing Arts in Suicide Prevention Strategies: A Scoping Review (2022) (0)
- Childhood Parenting Style as a Risk Factor for the Development of Obesity and BED in Adulthood: A Cross-Sectional Study (2019) (0)
- SUPERSENSITIVITY PSYCHOSIS. AUTHOR'S REPLY (1991) (0)
- Dr. McDougle and Colleagues Reply (2006) (0)
- Athletes Economic Evaluation of Strategies to Reduce Sudden Cardiac Death in Young (2013) (0)
- Cognitive, neuropsychological and emotional-behavioural functioning in a sample of children with myotonic dystrophy type 1. (2022) (0)
- Research Can Help Clarify the Benefits and Limitations of Psychiatric Medications in Children (2011) (0)
- Paths to postsecondary education enrollment among adolescents with and without childhood attention-deficit/hyperactivity disorder (ADHD): A longitudinal analysis of symptom and academic trajectories. (2022) (0)
- Knowledge Among Parents of Children Participating in a Randomized Clinical Trial (2005) (0)
- Factors Associated With Positive Outcomes in the Treatment of Bipolar Disorder in Children: (516692013-002) (2013) (0)
- Improving outcome of paediatric depression with cognitive–behavioural therapy (CBT) after initial improvement on antidepressant medication (2015) (0)
- Adolescent Depression: Phenotypic Complexity and Implications for Treatment (2011) (0)
- The song of Anorexia Nervosa: a specific evoked potential response to musical stimuli in affected subjects (0)
- Introduction: Psychopharmacotherapy in the developmental age (2006) (0)
- Children’s Yale–Brown Obsessive-Compulsive Scale--Pervasive Developmental Disorders Version (2017) (0)
- The song of Anorexia Nervosa: a specific evoked potential response to musical stimuli in affected participants (2020) (0)
- Promoting sexual health in transgender and gender diverse adolescents through an online sexuality psychoeducation program for parents: A case study. (2023) (0)
- 73-4 Pharmacological approaches to the treatment of HIV-related cognitive impairment (1997) (0)
- Brief Report: Social Disability in Autism Spectrum Disorder: Results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network Trials (2012) (0)
- Psychotic symptoms in ADHD:an analysis of the MTA database (2017) (0)
- Comfortably Numb: How Psychiatry Is Medicating a Nation (2009) (0)
- Corrigendum to "Do sub-syndromal manic symptoms influence outcome in treatment resistant depression in adolescents? A latent class analysis from the TORDIA study" [Journal of Affective Disorders 138, 1-2 (2012): 86-95]. (2019) (0)
- Emotional dysregulation during development: Implications for psychopathology (2018) (0)
- Treatment Approaches to Atypical Depression in the Elderly (1990) (0)
- This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. Combined Cognitive-Behavioural Therapy and Pharmacotherapy for Adolescent Depression it Improve Outcomes Compared with Monotherapy? (2009) (0)
- Hypericum perforatum extracts as potential antidepressants (1998) (0)
- Obituary for Alessandro Zuddas (2022) (0)
- Unmet Needs in Clinical Practice: A Proposal and Application of A Diagnostic and Severity Scale to Grade Cerebellar Mutism Syndrome (2021) (0)
- Is there a place for antidepressants in child and adolescent depression (2012) (0)
- Drug Challenge Strategies in Alzheimer Disease: (2020) (0)
- Learning with fun: the 2nd residential course on child and adolescent psychiatry in Catania, Sicily, endorsed by the ESCAP Research Academy (2023) (0)
- Editorial: Can Less Be More When Measuring Psychotic Symptoms in Youth? (2023) (0)
- Children at Risk for Schizophrenia: A Longitudinal Perspective—edited by Norman F. Watt, E. James Anthony, Lyman C. Wynne, and Jon E. Rolf; Cambridge University Press, New York, 1984, 658 pages, $39.50 (1986) (0)
- Children with panic disorder. (1990) (0)
- A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (2013) (0)
- Risperidone maintenance treatment increases time to symptom recurrence in young people with disruptive behaviour disorders (2006) (0)
- TADS critiques lack scientific rigor, accuracy and thus credibility (2017) (0)
- The Authors’ Reply (2012) (0)
- Pharmacologic treatment of children and adolescents with major depressive disorder (2006) (0)
- Children with panic disorder. Reply (1990) (0)
- Children with Prader-Willi Syndrome and COVID-19: a longitudinal study of the effect of social re-opening after the lockdown. (2023) (0)
- Editorial: On the Safety of Long-term Methylphenidate Treatment of Attention-Deficit/Hyperactivity Disorder in Early Childhood. (2021) (0)
- New journal structure of child and adolescent psychiatry and mental health (2016) (0)
- Children’s Global Assessment Scale (2021) (0)
- The Need for Specifically Targeted and Precise Treatments Aiming for Remission (2009) (0)
- Clinical Correlates of Parenting Stress in Children with Autism Spectrum Disorder and Serious Behavioral Problems (2019) (0)
- Supersensitivity psychosis [5] (1991) (0)
- Treating Depression in Adolescents (2011) (0)
- 189. Pediatric psychopharmacology: NIMH-sponsored multisite studies (2000) (0)
- Clinical Trials Methodology and Designs (2010) (0)
- Pediatric Anxiety Rating Scale (2002) (0)
- Challenges in assessing the therapeutic benefit of lithium in children and adolescents with bipolar disorder. (2019) (0)
- Pharmacotherapy of eating disorders in children and adolescents (2006) (0)
- On the need for further research on attention-deficit/hyperactivity disorder (2001) (0)
- Pediatric Cardiology Modeled Economic Evaluation of Alternative Strategies to Reduce Sudden Cardiac Death Among Children Treated for Attention Deficit/Hyperactivity Disorder (2010) (0)
- CORRECTION (2004) (0)
- Affectionless Control: A Risky Parenting Style for the Development of Obesity in Adulthood (2019) (0)
- ADHD Psychopharmacology Across the Lifespan Benedetto Vitiello , MD (0)
- Psychopharmacological Treatments for Mental Disorders in Patients with Neuromuscular Diseases: A Scoping Review (2022) (0)
- Increased serotonin uptake in platelets of obsessive-compulsive patients (1989) (0)
- 27.1 Paths to Postsecondary Education Enrollment Among Adolescents With and Without Childhood ADHD (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Benedetto Vitiello?
Benedetto Vitiello is affiliated with the following schools:
